APHA 2023

Engage with public health experts, collaborate with other advocates and grow professionally.

International Conference on Womens Health and Breast Cancer

Engage in the ICWHBC to gain insights from global experts, fostering collaboration and advancing knowledge in women's health and breast cancer research. Explore cutting-edge research findings and network with peers to drive innovation in these crucial areas of healthcare.

2nd International Conference on Women’s Health and Breast Cancer

Engage with global experts to explore recent trends and advancements in women's health and breast cancer research and treatment. Gain insights into core areas such as breast cancer types, treatments, and risk factors, while fostering collaboration and awareness in healthcare sectors.

ESMO Congress 2024

ESMO 2024 will disseminate the latest cutting-edge data, provide high quality education and excellent networking opportunities for oncologists and other stakeholders from all around the world.

EACR Cancer Metabolism

The EACR Conference on Cancer Metabolism delves into tumor metabolic adaptations and treatment strategies. Experts explore genomic and cellular signaling perturbations' impact, fostering a deeper understanding of cancer biology and innovative treatments.

Breast Cancer Risk and Genetics Program Masterclass

Content will include breast cancer risk assessment, breast imaging, hereditary breast cancer syndromes, management of risk-reducing medications, and use of hormones in women at increased risk for breast cancer.

4th European Congress on Cancer and Oncology Research

Learning prospective include interactive sessions, expert-led workshops, and cutting-edge research presentations, providing attendees with valuable insights and fostering professional development in the field.

2024 Seattle Lung Cancer Conference

Review the various actionable molecular abnormalities in lung cancer and learn about the appropriate testing and treatment strategies for these alterations, Summarize the efficacy and potential toxicities of immune checkpoint inhibitors, targeted therapies, and other chemotherapy agents in the management of lung cancer, Apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with lung cancer